| December 2018 |
| 31 Dec |
Top 10 drugs drive India revenue for big firms |
 |
| 30 Dec |
The books that inspired CEO's in 2018 |
|
| 25 Dec |
Top Indian pharma cos rake in moolah beatings odds |
|
| 25 Dec |
Biocon says won't play the bloodbath game in Indian market for now |
|
| 21 Dec |
Strong growth outlook for Biocon's biosimilar |
|
| 18 Dec |
USFDA okays Biocon Telangana plant |
|
| 12 Dec |
Edelweiss Day trading Guide |
|
| 07 Dec |
Roshini Nadar,
Mazumdar -Shaw among world's 100 most powerful women: Forbes |
|
| 05 Dec |
Billionaire Fastlane |
|
| 03 Dec |
Not a drop drained, revived Hebbagodi Lake opens |
|
| 03 Dec |
ET Top 500 |
|
| 03 Dec |
Bangalore has India's Largest Floating Island |
|
| 01 Dec |
Biocon, Mylan joint product gets EU nod |
|
| November 2018 |
| 29 Nov |
Biocon targets to be a global biopharma leader in 20yrs' |
|
| 09 Nov |
Realising an Audacious Dream |
|
| 09 Nov |
Quality takes centre stage as investors seek safety. |
|
| 08 Nov |
10 Outperformers Stocks of last Samvat and what the street Excepect Now |
|
| 07 Nov |
Biocon's Malaysia facilty on path to break even in FY19 |
|
| 01 Nov |
Biologics business more than doubled in Q2 |
|
| October 2018 |
| 26 Oct |
Biocon Sep-quarter net profit sees five-fold surge on exceptional income |
|
| 25 Oct |
Biocon Ranked 7th on Top Global Pharma & Biotech Employers List 2018 |
|
| 19 Oct |
CHMP nod for Ogivri Biocon and Mylan expect EC call by end of year |
|
| September 2018 |
| 24 Sep |
They were not comfortable about hiring a woman |
|
| 21 Sep |
Biocon closer to Europe approval of biosimilar Pegfilgrastim |
|
| 15 Sep |
Grit is her secret Formula |
|
| August 2018 |
| 1 Aug |
Biocon targets $200mn revenue from Biosimilars |
|
| July 2018 |
| 26 July |
Biocon posts 47% increase in 1st quarter net profit |
|
| 5 July |
Biocon gets EU GMP clearance for Bangalore facility |
|
| June 2018 |
| 6 June |
U.S. FDA approves Biocon-Mylan’s first biosimilar of cancer drug Neulasta |
|
| May 2018 |
| 20 May |
Biocon bets on R&D, biosimilars business to boost growth in FY19 |
|
| April 2018 |
| 26 Apr |
Biocon's profit inches up 2% in fourth quarter |
|
| March 2018 |
| 28 Mar |
Biocon, Mylan get EC nod to market biosimilar insulin glargine |
|
| February 2018 |
| 6 Feb |
Global pharma is moving to biotherapy, and that’s Biocon’s strength: Kiran Mazumdar-Shaw |
|
| January 2018 |
| 19 Jan |
Biocon teams up with Sandoz for next gen biosimilars |
|
